New RYBREVANT ® (amivantamab-vmjw) Data Showed Long-Term Clinical Response and Safety in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations Who Have Failed Prior Platinum-Based Chemotherapy
COPENHAGEN, DENMARK, March 29, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new long-term data from the CHRYSALIS study evaluating RYBREVANT® (amivantamab-vmjw) in patients with advanced non-small cell lung cancer (NSCLC) and epidermal growth factor receptor (EGFR) exon 20 insertion mutations whose disease progressed on prior platinum-based chemotherapy.1 Data from the study showed long-term response and safety in this population and were presented in an oral presentation at the 2023 European Lung Cancer Congress (ELCC) (Abstract #779).1In the analysis of the CHRYSALIS study, inve...
Source: Johnson and Johnson - March 29, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
All Types of Hormonal Birth Control Share a Slightly Increased Risk of Breast Cancer, Study Says
For people who want to prevent pregnancy, birth-control drugs come with an obvious reward. They also come with some small risks—including, for some forms, a slightly increased risk of breast cancer.
This has long been known about the most popular type: combined hormonal birth control, which is available in pill, patch, and ring form. These all contain both estrogen and progestin, a synthetic version of the naturally occurring reproductive hormone progesterone.
Less is known about the breast-cancer risks of progestin-only birth control, a type that’s growing in popularity because it only contains one hormone. B...
Source: TIME: Health - March 21, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized Drugs healthscienceclimate Source Type: news
‘ Ted Lasso ’ Cast Visits White House to Promote Mental Health Care
WASHINGTON (AP) — Fictional soccer coach Ted Lasso used a White House visit Monday to encourage people, even in politically divided Washington, to make it a point to check in often with friends, family and co-workers to “ask how they’re doing, and listen, sincerely,”
Comedian Jason Sudeikis, who plays the title character — an American coaching a soccer team in London — and other cast members were meeting with President Joe Biden and first lady Jill Biden to talk about how mental health contributes to overall well-being.
Mental health and looking after one another is a theme of the show, ...
Source: TIME: Health - March 20, 2023 Category: Consumer Health News Authors: Darlene Superville and Zeke Miller/AP Tags: Uncategorized Mental Health White House wire Source Type: news
Cancer vaccine is 'no-brainer' for little Arianna's family but they can't get it in the UK
EXCLUSIVE: Arianna's family are fundraising £ 350,000 for a trip to New York to access the treatment. (Source: Daily Express - Health)
Source: Daily Express - Health - March 20, 2023 Category: Consumer Health News Source Type: news
Age, Cancer Type Affect COVID-19 Vaccine Uptake in Cancer Patients
THURSDAY, March 16, 2023 -- For patients with cancer, age, cancer type, and comorbidity are associated with differential COVID-19 vaccine uptake rates, according to a study published online March 15 in Cancer.
Dax Kurbegov, M.D., from the Sarah... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 16, 2023 Category: Pharmaceuticals Source Type: news
Solar Powered Freezer Improving Immunization Coverage in Hard-to-Reach Rural Villages
Benson Musyoka rides his motorcycle from Kamboo health centre to transport vaccines to Yindalani village. Photo Joyce Chimbi/IPSBy Joyce ChimbiNAIROBI, Mar 13 2023 (IPS) Up until 2019, nurses in three health facilities located in the semi-arid south-eastern Kenya region of Makueni County struggled to bring critical health services closer to a hard-to-reach population scattered across three remote, far-flung villages.
“Kamboo, Yindalani and Yiuma Mavui villages are located 17 and 28 kilometres away from Makindu sub-county hospital, and 10 and 22 kilometres away from the nearest electricity grid,” Benson Musyoka, the nu...
Source: IPS Inter Press Service - Health - March 13, 2023 Category: International Medicine & Public Health Authors: Joyce Chimbi Tags: Africa COVID-19 Development & Aid Editors' Choice Featured Gender Headlines Health Humanitarian Emergencies TerraViva United Nations Women's Health IPS UN Bureau IPS UN Bureau Report Kenya Source Type: news
White House budget includes ambitious push to eliminate hepatitis C
The Biden administration's fiscal year 2024 budget proposal, announced yesterday, aims to eliminate hepatitis C from the United States by creating a nationwide program to fight the disease. If funded by Congress, the 5-year, $11.3 billion program would expand testing, broaden access to powerful antiviral drugs, and boost awareness.
“I can’t really recall a circumstance quite like this, where we have the chance to do something this groundbreaking, so we just have to figure out how to make it work,” Francis Collins, acting science adviser to President Joe Biden and former head of the National Institutes of Health...
Source: ScienceNOW - March 11, 2023 Category: Science Source Type: news
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
Study (n=1909) found overall, 16.6% of patients had at least one sequela from COVID-19 at the first oncological reassessment, with highest prevalence in pre-vaccination phase (191 of 1000 [19.1%]), confirming protective role of previous SARS-CoV-2 immunisation. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 10, 2023 Category: Consumer Health News Source Type: news
Seeking technology, manufacturing partnership with Indian pharma companies, says Mexico foreign secretary
The Mexican government has partnered with ImmunoAct, an IIT Bombay-incubated company which is developing cutting-edge chimeric antigen receptor - T cell (CAR -T), a gene therapy that has the potential to cure certain types of blood cancer. Mexico foreign secretary Marcelo Ebrard listed critical life-saving drugs such as cancer medications, antiretrovirals and vaccines where Mexico is seeking India ’s help. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 8, 2023 Category: Pharmaceuticals Source Type: news
New STELARA ® (ustekinumab) Long-Term Data Support its Established Safety Profile in Inflammatory Bowel Disease and Durable Efficacy in Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, March 4, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced final pooled long-term safety results for STELARA® (ustekinumab) through five years in adults with moderately to severely active Crohn’s disease (CD) and four years in adults with moderately to severely active ulcerative colitis (UC), as well as final four-year clinical and endoscopic outcomes from the UNIFI long-term extension (LTE) study evaluating the efficacy of STELARA for the treatment of adults with moderately to severely active UC.1,2 These data are a part of Janssen’s 22 oral and poster ...
Source: Johnson and Johnson - March 4, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
New weapon in the fight against cervical cancer
A new vaccine that trains the immune system to recognize and attack cervical cancer tumors shows promise in becoming a crucial aid in fighting the disease, complementing the HPV jab that has already reduced cases by almost 90% in England since 2008. (Source: Daily Express - Health)
Source: Daily Express - Health - March 3, 2023 Category: Consumer Health News Source Type: news
New vaccine could become key weapon in the fight against cervical cancer
A new vaccine that trains the immune system to recognize and attack cervical cancer tumours shows promise in becoming a crucial aid in fighting the disease, complementing the HPV jab that has already reduced cases by almost 90 percent in England since 2008. (Source: Daily Express - Health)
Source: Daily Express - Health - March 3, 2023 Category: Consumer Health News Source Type: news
Now We Need to Worry About Harmful ‘ Forever Chemicals ’ in Our Toilet Paper Too
In case you’re counting, the average American will go through 26 kg (57 lbs) of toilet paper in a single year. Multiply that by the 332 million people in the U.S. and you get more than 19 billion pounds of waste paper being flushed away annually. All by itself that represents a massive disposal and sanitation challenge.
But now, according to a paper just published in Environmental Science & Technology Letters there’s even more reason to be concerned: All of that toilet paper, including major brands sold around the world, turn out to be yet another source of PFAS, short for per- and polyfluoroalkyl substanc...
Source: TIME: Health - March 2, 2023 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized embargoed study Environmental Health healthscienceclimate Source Type: news
Janssen Launches Health Equity Campaign in Partnership with Award-Winning Radio Host D.L. Hughley to Raise Awareness About Multiple Myeloma Among Black Communities
HORSHAM, P.A., March 2, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the launch of That’s My Word™ to raise awareness of and help to drive better health outcomes for multiple myeloma among at-risk populations. A national campaign bringing together trusted voices among Black communities, including those at risk of multiple myeloma, care partners, healthcare professionals, advocacy groups and award-winning radio host and comedian D.L. Hughley, That’s My Word™ aims to be a source of both information and hope by sharing resources specifically for Black patients and their care p...
Source: Johnson and Johnson - March 2, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Janssen Submits New Drug Application to the U.S. Food and Drug Administration Seeking Approval of Niraparib and Abiraterone Acetate Dual-Action Tablet, Plus Prednisone, as a First-Line Targeted Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer with BRCA Gene Mutations
RARITAN, N.J., February 28, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of niraparib in combination with abiraterone acetate, in the form of a dual-action tablet (DAT), plus prednisone, for the treatment of patients with BRCA-positive metastatic castration-resistant prostate cancer (mCRPC). If approved, this will be the first DAT formulation available in the U.S. to patients with mCRPC with BRCA mutations, which are a type of homologous recombination repair (HRR) gene alt...
Source: Johnson and Johnson - March 1, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
